Neuralstem, Inc.
(NASDAQ : CUR)

( )
CUR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.80%108.001.1%$623.63m
GILDGilead Sciences, Inc.
2.24%75.880.9%$553.53m
AMGNAmgen Inc.
0.81%176.831.1%$472.09m
REGNRegeneron Pharmaceuticals, Inc.
0.14%381.322.7%$367.77m
BIIBBiogen Inc.
0.69%328.031.2%$319.81m
ALXNAlexion Pharmaceuticals, Inc.
-2.24%111.901.9%$254.48m
NKTRNektar Therapeutics
2.30%55.216.1%$211.68m
VRTXVertex Pharmaceuticals Incorporated
-1.34%141.681.9%$185.36m
ALNYAlnylam Pharmaceuticals, Inc
-2.06%128.2010.0%$179.97m
BLUEBluebird Bio, Inc.
17.91%201.8017.2%$170.21m
ILMNIllumina, Inc.
-1.63%214.113.5%$161.51m
AAgilent Technologies, Inc.
-0.65%66.941.5%$153.46m
INCYIncyte Corporation
0.69%97.252.5%$138.55m
BMRNBioMarin Pharmaceutical Inc.
7.46%88.114.4%$100.29m
JUNOJuno Therapeutics, Inc.
-14.34%50.2413.5%$94.10m

Company Profile

Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.